The Smart Investor
    Facebook Instagram
    Monday, June 5
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Kuo’s Smart Take»Smart Thought Of The Week: MVP
    Kuo’s Smart Take

    Smart Thought Of The Week: MVP

    David KuoBy David KuoSeptember 12, 2020Updated:September 12, 20202 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    The pausing of COVID-19 vaccine trials at AstraZeneca is a timely reminder that nothing in the sphere of scientific research is ever guaranteed. So, anyone who claims we could have a vaccine before November is either delusional or doesn’t understand science or both.

    That is not to say that the clinical trials won’t be resumed. But a vaccine that could be rolled out to billions of people around the world needs to be 100% safe. And a few short months is not long enough to determine if the vaccine will have any long-term adverse effects….

    …. It might work at preventing viral infections in thousands of test subjects. But that should only be just one of many considerations. A bigger question would be how might a vaccine that is, say, derived from an adenovirus virus found in chimpanzees affects us and future generations? That is not something that can be answered in a matter of months.

    Worryingly, the US government is pushing for a vaccine ahead of the upcoming presidential election. That scares me. A vaccine is not a fancy motorised scooter or a piece of operating software where a minimum viable product or MVP will do. This is not something that can be fixed on the fly after it has been injected into millions.

    That is why it is concerning that the US government is looking at fast-track authorisation of a vaccine – any vaccine. However, the World Health Organisation said this is not a race between companies, and it is not a race between countries. Instead, it’s a race against this virus, and it’s a race to save lives.

    Unfortunately, some political leaders believe that it is precisely that – a race between companies and a race between countries. For them, it is not a question of whether the vaccine is absolutely safe but whether it is a MVP that is good enough to deliver an economic rebound.

    If you’d like to learn more investing concepts, and how to apply them to your investing needs, sign up for our free investing education newsletter, Get Smart! Click HERE to sign up now. 

    Get more stock updates on our Facebook page. Click here to like and follow us on Facebook.

    Disclosure: David Kuo does shares in all the companies mentioned.

    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Smart Reads Pic 7

    Smart Reads of the Week: Mapletree Industrial Trust, Singapore Exchange and Blue-Chip Stocks That Increased Dividends

    June 3, 2023
    Smart Reads Pic 12

    Smart Reads of the Week: Singtel, Inflation-Beating Stocks and REITs with High Yield

    May 27, 2023

    Smart Thought Of The Week: Debt Ceiling

    May 21, 2023
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Subscription Terms of Service
    © 2023 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.